Outcomes in Moderate Mixed Aortic Valve Disease

RecruitingOBSERVATIONAL
Enrollment

1,900

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

December 1, 2026

Conditions
Mixed Aortic Valve Disease
Trial Locations (1)

2333ZA

RECRUITING

Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

collaborator

Queen Mary Hospital, Hong Kong

OTHER

collaborator

National Heart Centre Singapore

OTHER

collaborator

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

OTHER

lead

Leiden University Medical Center

OTHER